Insider · CIK 0001642996

CHEN JIN-LONG

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001642996

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-09	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,532
2023-03-02	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2023-03-02	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+192K sh	—	—	192,000
2023-03-02	NGM BIOPHARMACEUTICALS INCA Award	Director, Chief Scientific Officer	AAward	+64K sh	—	—	972,893
2023-01-17	NGM BIOPHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+85.1K sh	$1.44	+$123K	993,975
2023-01-17	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−85.1K sh	$5.15	−$438K	908,893
2023-01-17	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−85.1K sh	—	—	0
2022-06-10	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+39.7K sh	—	—	39,727
2022-03-03	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2021-12-07	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$18.60	−$279K	908,893
2021-12-06	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−69.4K sh	—	—	85,082
2021-12-06	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$18.21	−$273K	854,449
2021-12-06	NGM BIOPHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+69.4K sh	$1.44	+$100K	923,893
2021-11-15	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$19.56	−$293K	869,449
2021-11-15	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$19.89	−$298K	884,449
2021-10-12	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$20.14	−$302K	899,449
2021-10-11	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$20.41	−$306K	914,449
2021-09-14	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−3,037 sh	$26.13	−$79.4K	929,449
2021-09-14	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−12K sh	$25.54	−$306K	932,486
2021-09-13	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−3,920 sh	$25.59	−$100K	955,529
2021-09-13	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−170 sh	$26.98	−$4,586.6	944,449
2021-09-13	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−10.9K sh	$26.17	−$286K	944,619
2021-08-10	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−15K sh	$23.15	−$347K	959,449
2021-08-09	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−600 sh	$25.62	−$15.4K	974,449
2021-08-09	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−7,731 sh	$23.81	−$184K	981,718
2021-08-09	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−6,669 sh	$25.12	−$168K	975,049
2021-06-03	NGM BIOPHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+69.4K sh	$1.44	+$100K	989,449
2021-06-03	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−69.4K sh	—	—	0
2021-05-03	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$27.62	−$691K	920,005
2021-04-12	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$24.65	−$616K	945,005
2021-03-17	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2021-03-01	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$26.66	−$667K	970,005
2021-02-16	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$28.75	−$719K	995,005
2021-01-05	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−150K sh	—	—	0
2021-01-05	NGM BIOPHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+150K sh	$0.60	+$90K	1,020,005
2021-01-04	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−370 sh	$30.26	−$11.2K	870,005
2021-01-04	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−24.6K sh	$29.27	−$721K	870,375
2020-12-14	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−11.1K sh	$27.59	−$307K	908,879
2020-12-14	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−10.7K sh	$28.19	−$302K	898,150
2020-12-14	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−3,145 sh	$28.89	−$90.9K	895,005
2020-11-02	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$17.70	−$443K	920,005
2020-10-12	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$17.02	−$426K	945,005
2020-09-01	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−17.4K sh	$17.62	−$306K	977,618
2020-09-01	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−7,613 sh	$18.32	−$139K	970,005
2020-08-10	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−25K sh	$19.02	−$476K	995,005
2020-07-01	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−17.7K sh	$18.79	−$333K	1,027,268
2020-07-01	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−7,263 sh	$19.20	−$139K	1,020,005
2020-06-15	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−19.4K sh	$21.79	−$423K	1,045,005
2020-06-15	NGM BIOPHARMACEUTICALS INCS Sale	Director, Chief Scientific Officer	SSale	−5,600 sh	$21.15	−$118K	1,064,405
2020-02-04	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
Jun 124
CHEN JIN-LONG0001209191-23-036506
SEC(opens sec.gov)
Mar 64
CHEN JIN-LONG0001209191-23-016384
SEC(opens sec.gov)
Jan 184
CHEN JIN-LONG0001209191-23-003702
SEC(opens sec.gov)
Jun 134
CHEN JIN-LONG0001209191-22-036523
SEC(opens sec.gov)
Mar 44
CHEN JIN-LONG0001209191-22-016205
SEC(opens sec.gov)
Dec 74
CHEN JIN-LONG0001209191-21-068466
SEC(opens sec.gov)
Nov 164
CHEN JIN-LONG0001209191-21-064853
SEC(opens sec.gov)
Oct 134
CHEN JIN-LONG0001209191-21-060364
SEC(opens sec.gov)
Sep 144
CHEN JIN-LONG0001209191-21-056083
SEC(opens sec.gov)

Companies

Address

333 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080